8-KThe WireRoutine
Bylaw Amendment
Filed Feb 1, 2022 · 4y ago · Accession 0000075252-22-000003
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing text
View original ↗UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 31, 2022
Owens & Minor, Inc.
(Exact name of registrant as specified in its charter)
Virginia
001-09810 54-1701843
(State or other jurisdiction of
incorporation or organization)
(Commission
File Number) (I.R.S. Employer
Identification No.)
9120 Lockwood Boulevard,
Mechanicsville
Virginia
23116
(Address of principal executive offices)
(Zip Code)
Post Office Box 27626,
Richmond, Virginia
23261-7626
(Mailing address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (804) 723-7000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $2 par value per share OMI New York Stock Exchange
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 5.03.
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
Effective January 31, 2022, the Board of Directors (the “Board”) of Owens & Minor, Inc. (the “Company”) approved an amendment to Section 2.2 of Article II of the Company’s Amended and Restated Bylaws (the “Bylaws”) to decrease the size of the Board from eight directors to seven directors. This summary of the Bylaws is qualified in its entirety by the specific language of the Bylaws which are filed as an Exhibit to this Current Report on Form 8-K.
Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits.
3.1 Amended and Restated Bylaws of the Company effective January 31, 2022
104 Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
OWENS & MINOR, INC.
Date: February 1, 2022
By:
/s/ Nicholas J. Pace
Name:
Nicholas J. Pace
Title:
Executive Vice President, General Counsel and Corporate Secretary
Filing details
- Company
- ACCENDRA HEALTH INC/VA/
- Ticker
- ACH
- CIK
- 75252
- Form type
- 8-K
- Filing date
- Feb 1, 2022
- Report date
- Jan 31, 2022
- Document
- omi-20220131.htm
- Size
- 340 KB